Please enable JavaScript in your web browser settings, under the site permissions section to unlock full site functionality. Click here for help.

Article Image - OPKO Health Acquires EirGen Pharma

Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Scroll to keep reading

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy

You Might Also Like

MitonOptimal to Acquire Coram Asset Management in the UK

21/06/2016MitonOptimal to Acquire Coram Asset Management in the UK

MitonOptimal International, the Guernsey-headquartered discretionary fund management company, is to acquire Coram Asset Management Limited.

Most Innovative Firm in Hungary

05/05/2016Most Innovative Firm in Hungary

SBGK has been a significant actor in the Hungarian legal professional market since the 1970’s. It stands out with the thorough knowledge of the intellectual property law practice area.

5 Questions To Ask Before Putting AI Into Practice And A Checklist For Success

03/01/20205 Questions To Ask Before Putting AI Into Practice And A Checklist For Success

Despite the power of Artificial Intelligence to transform the customer experience, many AI projects fail at the first hurdle. Henry Jinman at EBI.AI outlines the 5 most common mistakes and how to avoid them using a tried and tested checklist.

What lessons has the pandemic taught us about the fluidity of labour in the run up to Brexit?

25/11/2020What lessons has the pandemic taught us about the fluidity of labour in the run up to Brexit?

So much time and angst has been spent on the B word since May 2016, much of it around the issue of fluidity of labour across borders. But what this year has shown is that technology and talent refuse to recognise borders: try building a wall in the cloud. So m

4 Ways to Prevent and Control Illness In the Workplace

23/11/20214 Ways to Prevent and Control Illness In the Workplace

Employees spend a lot of their time on business premises. They come in close contact with colleagues and use shared devices in the office. Consequently, this can increase their risk of exposure to harmful pollutants and viruses.

Most Outstanding Corporate Catering Services Provider 2021 – Australia

10/05/2022Most Outstanding Corporate Catering Services Provider 2021 – Australia

We catch up with the founder of Catering HQ, Steve Sidd, to discuss with him the nitty gritty of operating in the modern catering industry. With so many catering and hospitality companies offering similar – if not the same – menu items and services, Cateri

Read this month’s CPD Accredited Article to gain CPD Points

01/06/2016Read this month’s CPD Accredited Article to gain CPD Points

Read this month's CPD Accredited Article to gain CPD Points.

ICAP Acquires ENSO Financial Analytics

14/04/2016ICAP Acquires ENSO Financial Analytics

ICAP plc (IAP.L), a leading markets operator and provider of post trade risk mitigation and information services, announces today that it has acquired ENSO Financial Analytics (ENSO).

Generational Equity Announces the Acquisition of The HR Group Inc. by JER HR Consulting LLC

22/03/2016Generational Equity Announces the Acquisition of The HR Group Inc. by JER HR Consulting LLC

Generational Equity, a leading mergers and acquisitions advisor for privately-held, middle-market businesses, is pleased to announce the acquisition of its client, The HR Group Inc. headquartered in Greensboro, North Carolina.

View More Articles

Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

MORE BRANDS